These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 23758883)
21. Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine. Tahita MC; Tinto H; Erhart A; Kazienga A; Fitzhenry R; VanOvermeir C; Rosanas-Urgell A; Ouedraogo JB; Guiguemde RT; Van Geertruyden JP; D'Alessandro U PLoS One; 2015; 10(9):e0137440. PubMed ID: 26368675 [TBL] [Abstract][Full Text] [Related]
22. Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger. Grais RF; Laminou IM; Woi-Messe L; Makarimi R; Bouriema SH; Langendorf C; Amambua-Ngwa A; D'Alessandro U; Guérin PJ; Fandeur T; Sibley CH Malar J; 2018 Feb; 17(1):98. PubMed ID: 29486766 [TBL] [Abstract][Full Text] [Related]
23. Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda. Mbonye AK; Birungi J; Yanow SK; Shokoples S; Malamba S; Alifrangis M; Magnussen P Antimicrob Agents Chemother; 2015 Sep; 59(9):5475-82. PubMed ID: 26124154 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan. Ghanchi NK; Ursing J; Beg MA; Veiga MI; Jafri S; Mårtensson A Malar J; 2011 Jan; 10():18. PubMed ID: 21272384 [TBL] [Abstract][Full Text] [Related]
25. High prevalence of dihydrofolate reductase gene mutations in Plasmodium falciparum parasites among pregnant women in Nigeria after reported use of sulfadoxine-pyrimethamine. Ojurongbe O; Nguetse CN; Fayemiwo SA; Falade CO; Ojurongbe TA; Thomas BN; Meyer CG; Velavan TP Pathog Glob Health; 2018 Mar; 112(2):86-92. PubMed ID: 29318942 [TBL] [Abstract][Full Text] [Related]
26. Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi. Artimovich E; Schneider K; Taylor TE; Kublin JG; Dzinjalamala FK; Escalante AA; Plowe CV; Laufer MK; Takala-Harrison S J Infect Dis; 2015 Sep; 212(5):694-701. PubMed ID: 25672905 [TBL] [Abstract][Full Text] [Related]
27. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes. Sitali L; Mwenda MC; Miller JM; Bridges DJ; Hawela MB; Hamainza B; Mudenda-Chilufya M; Chizema-Kawesha E; Daniels RF; Eisele TP; Nerland AH; Chipeta J; Lindtjorn B Acta Trop; 2020 Dec; 212():105704. PubMed ID: 33002448 [TBL] [Abstract][Full Text] [Related]
28. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen. Bamaga OA; Mahdy MA; Lim YA Malar J; 2015 Dec; 14():516. PubMed ID: 26693691 [TBL] [Abstract][Full Text] [Related]
29. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda. Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575 [TBL] [Abstract][Full Text] [Related]
30. The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women. Gutman J; Kalilani L; Taylor S; Zhou Z; Wiegand RE; Thwai KL; Mwandama D; Khairallah C; Madanitsa M; Chaluluka E; Dzinjalamala F; Ali D; Mathanga DP; Skarbinski J; Shi YP; Meshnick S; ter Kuile FO J Infect Dis; 2015 Jun; 211(12):1997-2005. PubMed ID: 25564249 [TBL] [Abstract][Full Text] [Related]
31. Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in western Kenya. Lucchi NW; Okoth SA; Komino F; Onyona P; Goldman IF; Ljolje D; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S Antimicrob Agents Chemother; 2015 Jul; 59(7):3995-4002. PubMed ID: 25896703 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in the Democratic Republic of the Congo: emergence of highly resistant pfdhfr/pfdhps alleles. Nkoli Mandoko P; Rouvier F; Matendo Kakina L; Moke Mbongi D; Latour C; Losimba Likwela J; Ngoyi Mumba D; Bi Shamamba SK; Tamfum Muyembe JJ; Muepu Tshilolo L; Parzy D; Sinou V J Antimicrob Chemother; 2018 Oct; 73(10):2704-2715. PubMed ID: 30053021 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy. Ogouyèmi-Hounto A; Ndam NT; Kinde Gazard D; d'Almeida S; Koussihoude L; Ollo E; Azagnandji C; Bello M; Chippaux JP; Massougbodji A Malar J; 2013 May; 12():147. PubMed ID: 23634705 [TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in pfdhfr and pfdhps genes after five years of artemisinin combination therapy (ACT) implementation from urban Kolkata, India. Chatterjee M; Ganguly S; Saha P; Guha SK; Maji AK Infect Genet Evol; 2017 Sep; 53():155-159. PubMed ID: 28533179 [TBL] [Abstract][Full Text] [Related]
35. Molecular surveillance of anti-malarial resistance Pfdhfr and Pfdhps polymorphisms in African and Southeast Asia Plasmodium falciparum imported parasites to Wuhan, China. Jiang T; Cheng W; Yao Y; Tan H; Wu K; Li J Malar J; 2020 Nov; 19(1):434. PubMed ID: 33238987 [TBL] [Abstract][Full Text] [Related]
36. Two novel mutations of pfdhps K540T and I588F, affecting sulphadoxine-pyrimethamine-resistant response in uncomplicated falciparum malaria at Banjar district, South Kalimantan Province, Indonesia. Basuki S; Fitriah ; Riyanto S; Budiono ; Dachlan YP; Uemura H Malar J; 2014 Apr; 13():135. PubMed ID: 25187019 [TBL] [Abstract][Full Text] [Related]
37. Peripheral and Placental Prevalence of Sulfadoxine-Pyrimethamine Resistance Markers in Plasmodium falciparum among Pregnant Women in Southern Province, Rwanda. Alruwaili M; Uwimana A; Sethi R; Murindahabi M; Piercefield E; Umulisa N; Abram A; Eckert E; Munguti K; Mbituyumuremyi A; Gutman JR; Sullivan DJ Am J Trop Med Hyg; 2023 Nov; 109(5):1057-1062. PubMed ID: 37783456 [TBL] [Abstract][Full Text] [Related]
38. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India. Rana R; Khan N; Sandeepta S; Pati S; Das A; Bal M; Ranjit M Malar J; 2022 Dec; 21(1):394. PubMed ID: 36566182 [TBL] [Abstract][Full Text] [Related]
39. Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries. Srisutham S; Madmanee W; Kouhathong J; Sutawong K; Tripura R; Peto TJ; van der Pluijm RW; Callery JJ; Dysoley L; Mayxay M; Newton PN; Pongvongsa T; Hongvanthong B; Day NPJ; White NJ; Dondorp AM; Imwong M PLoS One; 2022; 17(12):e0278928. PubMed ID: 36525403 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy. Warsame M; Hassan AH; Hassan AM; Arale AM; Jibril AM; Mohamud SA; Barrette A; Muse AY; Yusuf FE; Nada RA; Amran JG Trop Med Int Health; 2017 Apr; 22(4):415-422. PubMed ID: 28151566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]